Barclays Maintains an 'Overweight' on WellPoint (WLP); Advantages in Assets, Products, Brand and Share; Now Execution
Tweet Send to a Friend
Barclays maintains an 'Overweight' on WellPoint (NYSE: WLP), PT $74.
Barclays analyst says, "We believe that WellPoint controls a preferred ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Barclays analyst says, "We believe that WellPoint controls a preferred ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
